Topical difluprednate for the treatment of Harada’s disease
Spencer M Onishi, Masumi G Asahi, Calvin Chou, Ron P Gallemore Retina Macula Institute, Torrance, CA, USA Purpose: To describe the use of topical difluprednate for treatment of patients who presented with Harada’s disease.Methods: Retrospective case series of patients managed wi...
Guardado en:
Autores principales: | Onishi SM, Asahi MG, Chou C, Gallemore RP |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2c615864caf9422e9d98fdefcea5d888 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Multifocal ERG and Microperimetry Changes in Response to Ranibizumab Treatment of Neovascular AMD: Randomized Phase 2 Open-Label Study
por: Asahi MG, et al.
Publicado: (2020) -
Spectral domain optical coherence tomography documented rapid resolution of pseudophakic cystoid macular edema with topical difluprednate
por: Chalam KV, et al.
Publicado: (2012) -
Topical Difluprednate for Early Corneal Graft Rejection After Penetrating Keratoplasty
por: Said OM, et al.
Publicado: (2020) -
Photodynamic therapy combined with antivascular endothelial growth factor treatment for recalcitrant chronic central serous chorioretinopathy
por: Asahi MG, et al.
Publicado: (2017) -
The role of difluprednate ophthalmic emulsion in clinical practice
por: Karim N Jamal, et al.
Publicado: (2009)